Lanean...
TP63 isoform expression is linked with distinct clinical outcomes in cancer
BACKGROUND: Half of muscle-invasive bladder cancer patients will relapse with metastatic disease and molecular tests to predict relapse are needed. TP63 has been proposed as a prognostic biomarker in bladder cancer, but reports associating it with clinical outcomes are conflicting. Since TP63 is exp...
Gorde:
| Argitaratua izan da: | EBioMedicine |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953644/ https://ncbi.nlm.nih.gov/pubmed/31927310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.11.022 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|